Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations

被引:5
|
作者
Makarik, Tatiana, V [1 ]
Abdullaev, Adhamjon O. [1 ]
Nikulina, Elena E. [1 ]
Treglazova, Svetlana A. [1 ]
Stepanova, Elena E. [1 ]
Subortseva, Irina N. [1 ]
Kovrigina, Alla M. [1 ]
Melikyan, Anait L. [1 ]
Kulikov, Sergei M. [1 ]
Sudarikov, Andrey B. [1 ]
机构
[1] Natl Res Ctr Hematol, Novy Zykovski Lane 4a, Moscow 125167, Russia
关键词
myeloproliferative neoplasms; polycythemia vera; primary myelofibrosis; essential thrombocythemia; JAK2; V617F; MPL W515L; K; CALR;
D O I
10.3390/genes12040559
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
JAK2 (Janus kinase 2) V617F, CALR (Calreticulin) exon 9, and MPL (receptor for thrombopoietin) exon 10 mutations are associated with the vast majority of Ph-negative chronic myeloproliferative neoplasms (MPNs). These mutations affect sequential stages of proliferative signal transduction and therefore, after the emergence of one type of mutation, other types should not have any selective advantages for clonal expansion. However, simultaneous findings of these mutations have been reported by different investigators in up to 10% of MPN cases. Our study includes DNA samples from 1958 patients with clinical evidence of MPN, admitted to the National Research Center for Hematology for genetic analysis between 2016 and 2019. In 315 of 1402 cases (22.6%), CALR mutations were detected. In 23 of these 315 cases (7.3%), the JAK2 V617F mutation was found in addition to the CALR mutation. In 16 from 24 (69.6%) cases, with combined CALR and JAK2 mutations, V617F allele burden was lower than 1%. A combination of JAK2 V617F with MPL W515L/K was also observed in 1 out of 1348 cases, only. JAK2 allele burden in this case was also lower than 1%. Additional mutations may coexist over the low background of JAK2 V617F allele. Therefore, in cases of detecting MPNs with a low allelic load JAK2 V617F, it may be advisable to search for other molecular markers, primarily mutations in exon 9 of CALR. The load of the combined mutations measured at different time points may indicate that, at least in some cases, these mutations could be represented by different clones of malignant cells.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Relationship between JAK2V617F mutation, allele burden and coagulation function in Ph-negative myeloproliferative neoplasms
    Hu, Linhui
    Pu, Lianfang
    Ding, Yangyang
    Li, Manman
    Cabanero, Michael
    Xie, Jingxin
    Zhou, Dejun
    Yang, Dongdong
    Zhang, Cui
    Wang, Huiping
    Zhai, Zhimin
    Ru, Xiang
    Li, Jingrong
    Xiong, Shudao
    HEMATOLOGY, 2017, 22 (06) : 354 - 360
  • [22] JAK2 V617F ALLELE BURDEN AND VASCULAR COMPLICATION OCCURRENCE RISK IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
    Borowczyk, M.
    Lewandowski, K.
    Wojtaszewska, M.
    Gil, L.
    Lewandowska, M.
    Lehmann-Kopydlowska, A.
    Kroll-Balcerzak, R.
    Balcerzak, A.
    Iwola, M.
    Michalak, M.
    Komarnicki, M.
    HAEMATOLOGICA, 2014, 99 : 129 - 129
  • [23] Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN)
    Zulkeflee, Razan Hayati
    Zulkafli, Zefarina
    Johan, Muhammad Farid
    Husin, Azlan
    Islam, Md Asiful
    Hassan, Rosline
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (14)
  • [24] JAK2 V617F Allele Burden in Non-CML Classical Subtypes of Myeloproliferative Neoplasms (MPN)
    Gober-Wilcox, J.
    Vennapusa, B.
    Pierce, J.
    Vasef, M. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 581 - 581
  • [25] JAK2 V617F Mutation Allele Burden (MAB) and Its Correlation with Hematologic Characteristics in Myeloproliferative Neoplasms
    Kim, David Y.
    Tariq, Hamza
    Brown, Alan F.
    Vadlamudi, Kumari
    Wang, Yao
    Ikoma, Shohei
    Holder, Kenneth N.
    Higgins, Russell A.
    Fan, Hongxin
    BLOOD, 2017, 130
  • [26] JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis
    Kim, Bo Hyun
    Cho, Young-Uk
    Bae, Mi-Hyun
    Jang, Seongsoo
    Seo, Eul-Ju
    Chi, Hyun-Sook
    Choi, Yunsuk
    Kim, Dae-Young
    Lee, Jung-Hee
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    Park, Young-Mi
    Lee, Jong-Keuk
    Park, Chan-Jeoung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (07) : 882 - 888
  • [27] The JAK2 V617F mutational status and allele burden
    Liang, Shanshan
    Zhou, Yanhong
    THROMBOSIS RESEARCH, 2015, 136 (03) : 690 - 690
  • [28] The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience
    Najm, Maysam Basim
    Jalal, Sana Dlawar
    Getta, Hisham Arif
    CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (08) : 202 - 209
  • [29] JAK2 V617F mutation detection in chronic myeloproliferative neoplasms by digital PCR
    Waterhouse, M.
    Pfeifer, D.
    Follo, M.
    Bertz, H.
    Finke, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 196 - 196
  • [30] FREQUENCY OF JAK2 EXON 12 MUTATIONS IN JAK2 (V617F) NEGATIVE PATIENTS WITH CHRONIC MYELOPROLIFERATIVE DISORDERS (CMD)
    Bernardi, M.
    Ruggeri, M.
    Albiero, E.
    Madeo, D.
    Rodeghiero, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 294 - 294